The Evolution of CRPC and the Role of Bone Targeted Agents – Dr. Karim FizaziPublished January 29, 2014
Speakers: Karim Fizazi
This webcast has not been CME accredited. No credits will be given for watching.
You have already watched this webcast and been given a CME credit
You can earn a CME credit by watching this video and submiting the form below
Tuesday, February 4, 2014 @ 6:30pm ET
Karim Fizazi, MD, PhD
Head, Department of Cancer Medicine Institut Gustave Roussy, Villejuif, France